Inhibition of Ribonucleotide Reductase Subunit 2 (RRM2) Induces Radiosensitization in Gastroenteropancreatic Neuroendocrine Tumors

被引：0
|
作者：
Chow, Z. [1 ]
Johnson, J. [1 ]
Chauhan, A. [1 ]
Izumi, T. [1 ]
Cavnar, M. [1 ]
Weiss, H. [1 ]
Anthony, L. [1 ]
Evers, B. M. [1 ]
Rychahou, P. [1 ]
机构：
[1] Univ Kentucky, Lexington, KY USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1113
引用
收藏
页码：S160 / S160
页数：1
相关论文
共 50 条
  • [41] Neuroendocrine tumors of the gastroenteropancreatic system .2. Therapeutic advances
    Scherubl, H
    Buhr, H
    Faiss, S
    Zimmer, T
    Riecken, EO
    Wiedenmann, B
    ONKOLOGIE, 1996, 19 (03): : 214 - 219
  • [42] CXCR2 is Highly Expressed in Gastroenteropancreatic Neuroendocrine Tumors
    Logan, Kristen
    Huang, Jiaoti
    Morse, Michael
    Shi, Chanjuan
    MODERN PATHOLOGY, 2022, 35 : 488 - 489
  • [43] CXCR2 is Highly Expressed in Gastroenteropancreatic Neuroendocrine Tumors
    Logan, Kristen
    Huang, Jiaoti
    Morse, Michael
    Shi, Chanjuan
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 488 - 489
  • [44] Tumor suppressor FOXO3 regulates ribonucleotide reductase subunit RRM2B and impacts on survival of cancer patients
    Cho, Er-Chieh
    Kuo, Mei-Ling
    Liu, Xiyong
    Yang, Lixin
    Hsieh, Yi-Chen
    Wang, Jinghan
    Cheng, Yawen
    Yen, Yun
    ONCOTARGET, 2014, 5 (13) : 4834 - 4844
  • [45] Novel human-derived EML4-ALK fusion cell lines identify ribonucleotide reductase RRM2 as a target of activated ALK in NSCLC
    Bokhari, A. A.
    Lai, W-Y
    Le, A. T.
    Gabre, J. L.
    Chuang, T-P
    Fransson, S.
    Bergman, B.
    Djos, A.
    Chen, N.
    Martinsson, T.
    Van den Eynden, J.
    Doebele, R. C.
    Palmer, R. H.
    Hallberg, B.
    Umapathy, G.
    LUNG CANCER, 2022, 171 : 103 - 114
  • [46] Novel Human-derived EML4-ALK Fusion cell lines identify ribonucleotide reductase RRM2 as a Target of Activated ALK in NSCLC
    Umapathy, G.
    Bokhari, A.
    Lai, W. -Y.
    Le, A.
    Chuang, T. -P.
    Fransson, S.
    Martinsson, T.
    Van den Eynden, J.
    Doebele, R.
    Palmer, R. H.
    Hallberg, B.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S591 - S591
  • [47] Implication of ATM-/ATR-Chk1-E2F1-dependent up-regulation of ribonucleotide reductase R2 (RRM2) in DNA damage response
    Zhang, Yongwei
    Jones, Tamara
    Martin, Scott
    Caplen, Natasha
    Pommier, Yves
    CANCER RESEARCH, 2009, 69
  • [48] Ribonucleotide reductase M2 subunit as novel target for liposarcoma
    Geha, Rula C.
    Wu, Vicotria
    DeCarolis, Penelope
    O'Connor, Rachael
    Chen, JinHong
    Schwartz, Gary
    Singer, Samuel
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 203 (03) : S86 - S86
  • [49] A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors
    Li, Yaqun
    Fu, Wenhuan
    Geng, Zikai
    Song, Yun
    Yang, Xionggang
    He, Tianye
    Wu, Jian
    Wang, Bin
    PEERJ, 2022, 10
  • [50] Modeling inhibition of ribonucleotide reductase by 2-substituted hexofuranoses
    Mudgal, Mukesh M.
    Wnuk, Stanislaw F.
    Robins, Morris J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
12345